About Remidio
Remidio is a company based in Bengaluru (India) founded in 2009 by Anand Sivaraman.. Remidio has raised $25.01 million across 10 funding rounds from investors including Sun Pharma, KITVEN and Montane Ventures. The company has 135 employees as of April 06, 2024. Remidio offers products and services including Fundus On Phone, Portable Slit Lamp, Medios DR, and Instaref R20. Remidio operates in a competitive market with competitors including Forus Health, Beijing Digital Precision Medical Technology, TowardPi, Topconhealthcare and Wavefront Dynamics, among others.
- Headquarter Bengaluru, India
- Employees 135 as on 06 Apr, 2024
- Founders Anand Sivaraman
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Remidio Innovative Solutions Private Limited
- Date of Incorporation 19 Nov, 2009
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$4.85 M (USD)41.17as on Mar 31, 2023
-
Net Profit
$-1.07 M (USD)-212.46as on Mar 31, 2023
-
EBITDA
$-1.24 M (USD)-637.41as on Mar 31, 2023
-
Total Equity Funding
$25.01 M (USD)
in 10 rounds
-
Latest Funding Round
$18.09 M (USD), Series B
Feb 19, 2023
-
Investors
Sun Pharma
& 26 more
-
Employee Count
135
as on Apr 06, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Remidio
Remidio offers a comprehensive portfolio of products and services, including Fundus On Phone, Portable Slit Lamp, Medios DR, and Instaref R20. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Device for non-mydriatic fundus imaging and eye health monitoring.
Handheld device for slit imaging in ophthalmic examinations.
AI tool for screening diabetic retinopathy offline.
Aberrometer for eye measurements and diagnostics.
Unlock access to complete
Funding Insights of Remidio
Remidio has successfully raised a total of $25.01M across 10 strategic funding rounds. The most recent funding activity was a Series B round of $18.09 million completed in February 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Series B — $18.1M
-
First Round
First Round
(15 May 2015)
- Investors Count 27
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2023 | Amount | Series B - Remidio | Valuation | Sun Pharma |
|
| Jun, 2021 | Amount | Series B - Remidio | Valuation | Anand Sivaraman , Zubin Daruwalla | |
| Nov, 2020 | Amount | Grant - Remidio | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Remidio
Remidio has secured backing from 27 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Sun Pharma, KITVEN and Montane Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Technology startups are funded by Pureland Group through venture capital.
|
Founded Year | Domain | Location | |
|
Venture capital fund partnering with entrepreneurs in technology and health sectors.
|
Founded Year | Domain | Location | |
|
Deep tech investments in AI and 4th industrial revolution technologies across Europe.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Remidio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Remidio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Remidio Comparisons
Competitors of Remidio
Remidio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Forus Health, Beijing Digital Precision Medical Technology, TowardPi, Topconhealthcare and Wavefront Dynamics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Manufacturer of portable digital eye imaging devices and cloud-based healthcare platforms
|
|
| domain | founded_year | HQ Location |
Intraoperative optical molecular imaging navigation solutions are provided.
|
|
| domain | founded_year | HQ Location |
OCT and optical biometers are developed for ophthalmic disease diagnosis.
|
|
| domain | founded_year | HQ Location |
Offers medical devices and software for ophthalmic diagnostics and patient care.
|
|
| domain | founded_year | HQ Location |
Developer of advanced wavefront sensing technology for vision correction. This technology measures imperfections in the eye to optimize visual performance. A key product is a high-resolution wavefront sensor system providing diagnostic data for enhanced vision quality. The company is also developing wavefront-based corrections for various vision-correcting lens platforms.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Remidio
Frequently Asked Questions about Remidio
When was Remidio founded?
Remidio was founded in 2009 and raised its 1st funding round 6 years after it was founded.
Where is Remidio located?
Remidio is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Who is the current CEO of Remidio?
Anand Sivaraman is the current CEO of Remidio. They have also founded this company.
Is Remidio a funded company?
Remidio is a funded company, having raised a total of $25.01M across 10 funding rounds to date. The company's 1st funding round was a Grant of $10K, raised on May 15, 2015.
How many employees does Remidio have?
As of Apr 06, 2024, the latest employee count at Remidio is 135.
What is the annual revenue of Remidio?
Annual revenue of Remidio is $4.85M as on Mar 31, 2023.
What does Remidio do?
Remidio was founded in 2009 in Bengaluru, India, focusing on the healthcare sector with an emphasis on ophthalmology. AI and telemedicine are integrated into portable digital devices for eye testing and diagnosis. Products such as Fundus on Phone (FOP-NM), Portable Slit Lamp (PSL-D20), Instaref R20, Anterior Imaging Module (AIM), and Microscope Recording Device (MRD) are offered to support screening operations.
Who are the top competitors of Remidio?
Remidio's top competitors include Forus Health, Cyclops MedTech and Wavefront Dynamics.
What products or services does Remidio offer?
Remidio offers Fundus On Phone, Portable Slit Lamp, Medios DR, and Instaref R20.
Who are Remidio's investors?
Remidio has 27 investors. Key investors include Sun Pharma, KITVEN, Montane Ventures, Pureland Group, and Yongfah Capital.
What is Remidio's valuation?
The valuation of Remidio is $67.5M as of Feb 2023.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.